From: Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy
FEV1(L/%) | ||||
---|---|---|---|---|
Evaluation I | Evaluation II | Evaluation III | ||
Age (≤10 years) | 1.3 ± 0.3/72.5 ± 17.14 | 1.5 ± 0.5/77.4 ± 20.8 | 1.3 ± 0.4/69.1 ± 22 | p1 = 0.35/0.43 |
n = 9 | p2 = 0.16/0.17 | |||
Age (>10 years) | 1.5 ± 0.4/64.3 ± 20.6 | 1.5 ± 0.3/64.5 ± 22.5 | 1.5 ± 0.3/61.8 ± 22.3 | p3 = 0.13/0.16 |
n = 12 | ||||
Age of onset of steroid | 1.3 ± 0.3 / 71.6 ± 19.1 | 1.5 ± 0.5 / 76.2 ± 24.8 | 1.4 ± 0.5 / 72.1 ± 26.6 | p1 = 0.32/0.38 |
therapy (≤7 years) | p2 = 0.05/0.22 | |||
p3 = 0.18/0.18 | ||||
n = 10 | ||||
Age of onset of steroid | 1.5 ± 0.4 / 64.3 ± 19.6 | 1.5 ± 0.3 / 64.3 ± 19 | 1.4 ± 0.2 / 58.5 ± 15.2 | |
therapy (>7 years) | ||||
n = 11 | ||||
Ambulant | 1.4 ± 0.3 / 80.4 ± 13.9 | 1.6 ± 0.4 / 87.8 ± 15.9 | 1.6 ± 0.3 / 82.1 ± 19.1 | p1 = 0.42/0.41 |
p2 = 0.18/0.98 | ||||
n = 9 | p3 = 0.50/0.38 | |||
Non-ambulant | 1.4 ± 0.4 / 58.3 ± 17.5 | 1.4 ± 0.4 / 56.7 ± 16.1 | 1.3 ± 0.3 / 52.2 ± 13.9 | |
n = 12 |